Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

1.

Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinoma.

Jonasch E, Wood CG, Matin SF, Tu SM, Pagliaro LC, Corn PG, Aparicio A, Tamboli P, Millikan RE, Wang X, Araujo JC, Arap W, Tannir N.

J Clin Oncol. 2009 Sep 1;27(25):4076-81. doi: 10.1200/JCO.2008.21.3660. Epub 2009 Jul 27.

PMID:
19636008
[PubMed - indexed for MEDLINE]
Free Article
2.

Tolerability of first-line therapy for metastatic renal cell carcinoma.

Porta C, Szczylik C.

Cancer Treat Rev. 2009 May;35(3):297-307. doi: 10.1016/j.ctrv.2008.12.003. Epub 2009 Feb 26. Review.

PMID:
19249157
[PubMed - indexed for MEDLINE]
3.

Bevacizumab: in first-line treatment of advanced and/or metastatic renal cell carcinoma.

Frampton JE, Keating GM.

BioDrugs. 2008;22(2):113-20. Review.

PMID:
18345708
[PubMed - indexed for MEDLINE]
4.

Multi-modal treatment for metastatic renal cancer: the role of surgery.

Russo P.

World J Urol. 2010 Jun;28(3):295-301. doi: 10.1007/s00345-010-0530-x. Epub 2010 Apr 4. Review.

PMID:
20364382
[PubMed - indexed for MEDLINE]
5.

Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation.

Thompson Coon J, Hoyle M, Green C, Liu Z, Welch K, Moxham T, Stein K.

Health Technol Assess. 2010 Jan;14(2):1-184, iii-iv. doi: 10.3310/hta14020. Review.

PMID:
20028613
[PubMed - indexed for MEDLINE]
Free Article
6.

Exploring the role of novel agents in the treatment of renal cell carcinoma.

Maluf FC, Fernandes Gdos S, Kann AG, Aguilar-Ponce JL, de la Garza J, Buzaid AC.

Cancer Treat Rev. 2008 Dec;34(8):750-60. doi: 10.1016/j.ctrv.2008.07.002. Epub 2008 Sep 17. Review.

PMID:
18801619
[PubMed - indexed for MEDLINE]
7.

Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness.

Thompson Coon JS, Liu Z, Hoyle M, Rogers G, Green C, Moxham T, Welch K, Stein K.

Br J Cancer. 2009 Jul 21;101(2):238-43. doi: 10.1038/sj.bjc.6605167. Epub 2009 Jun 30. Review.

PMID:
19568242
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancer.

Degirmenci M, Karaca B, Gorumlu G, Durusoy R, Demir Piskin G, Bozkurt MT, Cirak Y, Tunali D, Karabulut B, Sanli UA, Uslu R.

Med Oncol. 2010 Sep;27(3):585-91. doi: 10.1007/s12032-009-9253-5. Epub 2009 Jun 13. Review.

PMID:
19526201
[PubMed - indexed for MEDLINE]
9.

Can inhibition of angiogenic pathways increase the efficacy of intravenous 5-fluorouracil-based regimens?

Kabbinavar FF, Ellis LM.

Clin Colorectal Cancer. 2004 Oct;4 Suppl 2:S69-73. Review.

PMID:
15479482
[PubMed - indexed for MEDLINE]
10.

ICUD-EAU International Consultation on Kidney Cancer 2010: treatment of metastatic disease.

Patard JJ, Pignot G, Escudier B, Eisen T, Bex A, Sternberg C, Rini B, Roigas J, Choueiri T, Bukowski R, Motzer R, Kirkali Z, Mulders P, Bellmunt J.

Eur Urol. 2011 Oct;60(4):684-90. doi: 10.1016/j.eururo.2011.06.017. Epub 2011 Jun 24. Review.

PMID:
21704448
[PubMed - indexed for MEDLINE]
11.

Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies.

Shih T, Lindley C.

Clin Ther. 2006 Nov;28(11):1779-802. Review.

PMID:
17212999
[PubMed - indexed for MEDLINE]
12.

Investigating the potential of bevacizumab in other indications: metastatic renal cell, non-small cell lung, pancreatic and breast cancer.

de Gramont A, Van Cutsem E.

Oncology. 2005;69 Suppl 3:46-56. Epub 2005 Nov 21. Review.

PMID:
16301835
[PubMed - indexed for MEDLINE]
13.

Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer.

Tappenden P, Jones R, Paisley S, Carroll C.

Health Technol Assess. 2007 Mar;11(12):1-128, iii-iv. Review.

PMID:
17346499
[PubMed - indexed for MEDLINE]
Free Article
14.

Targeted therapies and complete responses in first line treatment of metastatic renal cell carcinoma. A meta-analysis of published trials.

Iacovelli R, Alesini D, Palazzo A, Trenta P, Santoni M, De Marchis L, Cascinu S, Naso G, Cortesi E.

Cancer Treat Rev. 2014 Mar;40(2):271-5. doi: 10.1016/j.ctrv.2013.09.003. Epub 2013 Sep 11. Review.

PMID:
24070900
[PubMed - indexed for MEDLINE]
15.

Antiangiogenic therapies in early-stage breast cancer.

Derleth C, Mayer IA.

Clin Breast Cancer. 2010;10 Suppl 1:E23-31. doi: 10.3816/CBC.2010.s.004. Review.

PMID:
20587404
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Chemotherapy in metastatic renal cell carcinoma today? A systematic review.

Buti S, Bersanelli M, Sikokis A, Maines F, Facchinetti F, Bria E, Ardizzoni A, Tortora G, Massari F.

Anticancer Drugs. 2013 Jul;24(6):535-54. doi: 10.1097/CAD.0b013e3283609ec1. Review.

PMID:
23552469
[PubMed - indexed for MEDLINE]
17.

Combination therapy for renal cell cancer: what are possible options?

Santos N, Wenger JB, Havre P, Liu Y, Dagan R, Imanirad I, Ivey AM, Zlotecki RA, Algood CB, Gilbert SM, Allegra CJ, Okunieff P, Vieweg J, Dang NH, Luesch H, Dang LH.

Oncology. 2011;81(3-4):220-9. doi: 10.1159/000333470. Epub 2011 Nov 12. Review.

PMID:
22085914
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Surgical management of locally advanced and metastatic renal cancer: neoadjuvant and adjuvant strategies.

Pignot G, Drai J, Patard JJ.

Minerva Urol Nefrol. 2014 Mar;66(1):49-55. Review.

PMID:
24721940
[PubMed - indexed for MEDLINE]
19.

Management of favorable-risk patients with metastatic renal cell carcinoma: when to start and when to stop targeted therapy.

Powles T, Albers P.

Clin Genitourin Cancer. 2012 Dec;10(4):213-8. doi: 10.1016/j.clgc.2012.06.002. Epub 2012 Aug 30. Review.

PMID:
22939100
[PubMed - indexed for MEDLINE]
20.

Refining the use of cytoreductive nephrectomy in metastatic renal cell carcinoma.

La Rochelle J, Wood C, Bex A.

Semin Oncol. 2013 Aug;40(4):429-35. doi: 10.1053/j.seminoncol.2013.05.007. Review.

PMID:
23972706
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk